Delivery Order SPE2DB20D2014-SPE2DB24FB57T
Award Date 4/10/24
Potential Completion Date 4/11/24
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,904.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of emtricitabine-tenofovir 200-300 mg pharmaceutical products. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of pharmaceutical products such as emtricitabine-tenofovir 200-300 mg tablets. The $2,801.00 firm-fixed-price contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,672.26 to provide 4,563,918,225 units of the pharmaceutical product emtricitabine-tenofovir 200-300 mg. The contract has a period of performance through March 12, 2024 and was not set aside for any specific socioeconomic program. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 26, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $2,267.03, is scheduled for completion by July 28, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.48 to AmerisourceBergen Drug Corp for the supply of Emtricitabine-Tenofovir 200-300mg tablets in a 30-day supply package. This non-competitive delivery order, issued on October 30, 2025, represents a firm fixed-price procurement of pharmaceutical products with an ultimate completion date of October 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,350.48, is for the delivery of emtricitabine-tenofovir 200-300 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of November 30, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,555 to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir disoproxil fumarate combination tablets. The order is for 30 units of the medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania within the period of September 11-12, 2023. As a top pharmaceutical distributor, Amerisourcebergen Drug Corporation will leverage its...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,878.79 firm fixed-price contract is to provide emtricitabine-tenofovir 200-300 mg tablets. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of emtricitabine-tenofovir 200-300 mg pharmaceutical products, with a completion date of January 26, 2024 and a potential value of $2,184.17. Amerisourcebergen Drug Corp serves as the prime contractor, providing...
- The U.S. Defense Department's Medical Supply Chain awarded a firm fixed-price delivery order valued at $3,620.08 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Emtricitabine-Tenofovir 200-300 mg tablets in quantities of 30. This non-competitive delivery order, which serves military and federal healthcare systems, represents a single transaction under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. The pharmaceutical products will be...